| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/05/1997 | WO1997019701A2 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 06/05/1997 | WO1997019687A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | WO1997019683A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 06/05/1997 | DE19648566A1 Isotonic lipid emulsion for parenteral application for nourishment, |
| 06/05/1997 | CA2239206A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | CA2237956A1 2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones |
| 06/05/1997 | CA2236794A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/04/1997 | EP0776969A2 Process to prepare proteins by controlled proteolysis of pro-proteins |
| 06/04/1997 | EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 06/04/1997 | EP0776217A1 A method of treating a patient with a biologically active compound |
| 06/04/1997 | EP0776182A1 Therapeutic use of acetazolamide for the treatment of brain edema |
| 06/04/1997 | EP0621784B1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 06/04/1997 | EP0552269B1 Platelet adhesion inhibitor |
| 06/04/1997 | CN1151157A Metalloproteinase inhibitors |
| 06/04/1997 | CN1150907A Traditional Chinese patent medicine for strengthening spleen and appetizing and its preparation method |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
| 06/03/1997 | US5635162 Hemostatic composition for treating gingival area |
| 06/03/1997 | CA2004350C Propenone oxime ethers, a method of preparing them, and pharmaceutical compositions containing them |
| 05/29/1997 | WO1997019173A1 Method of treating sepsis |
| 05/29/1997 | WO1997019081A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018834A1 Therapeutic fragments of von willebrand factor |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775711A1 Peptide having antithrombotic activity and process for producing the same |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775157A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 05/28/1997 | EP0775141A1 Phenyl xanthine derivatives |
| 05/28/1997 | EP0710107A4 N,n,n-trimethylsphingosine derivatives |
| 05/28/1997 | EP0708775B1 TRICYCLIC INHIBITORS OF THE GPII b III a RECEPTOR |
| 05/28/1997 | EP0688336B1 Peptide boronic acid derivatives having protease inhibiting activity |
| 05/28/1997 | EP0581904B1 Method of inhibiting fibrosis |
| 05/28/1997 | EP0468054B1 Benzenesulfonamide derivative |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150799A Benzoheterocyclic derivatives |
| 05/28/1997 | CN1150756A Stable protein: phospholipid composition and method |
| 05/28/1997 | CN1150589A New sulfuric acid esters of sugar alcohols |
| 05/27/1997 | US5633350 Method for the isolation and purification of vitamin K-dependent proteins |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/22/1997 | WO1997018236A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 05/22/1997 | WO1997018214A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997018213A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017992A1 Improved formulation for administration of steroid compounds |
| 05/22/1997 | WO1997017985A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017973A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017968A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017965A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017964A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017963A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017961A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017959A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017958A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017957A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017851A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017850A1 Hemoregulatory compounds |
| 05/21/1997 | EP0774261A2 Uses of von Willebrand Factor and pharmaceutical preparations |
| 05/21/1997 | EP0774259A1 New use of organic compounds |
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773955A1 New thrombin inhibitors, their preparation and use |
| 05/21/1997 | EP0773949A1 D-mannose or xylitol esters and their use as drugs |
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0527821B1 Oxidation resistant thrombomodulin analogs |
| 05/21/1997 | CN1150458A Hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF for hematopoietic stimulation |
| 05/21/1997 | CN1150048A Protein granule composition suitable for intravenous injection |
| 05/21/1997 | CN1150047A Protein granules suitable for intravenous injection |
| 05/20/1997 | US5631365 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/20/1997 | US5631219 Method of stimulating hematopoiesis with hemoglobin |
| 05/20/1997 | US5631019 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 05/20/1997 | CA2019841C 4,5-dihydro-6h-imidazo[4,5,1-ij]quinolin-6-one-6- oxime-o-sulfonic acid derivatives |
| 05/15/1997 | WO1997017363A1 Thrombin inhibitors |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017072A2 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 05/15/1997 | DE19541405A1 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen Use of flupirtine for the prophylaxis and therapy of diseases which are associated with impairment of the hematopoietic cell system |
| 05/15/1997 | CA2235586A1 Thrombin inhibitors |
| 05/14/1997 | EP0772452A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix |
| 05/14/1997 | EP0772450A1 Methods for treating bleeding disorders |
| 05/14/1997 | CN1149877A Novel elastase inhibitor |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629324 Anticoagulants |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629309 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/13/1997 | US5629293 Single chain peptide compounds having hemoregulatory activity |
| 05/13/1997 | US5629176 Dna construct comprising dna sequence encoding the variant; recombinant expression vector comprising the construct; host cell containing the construct or vector; culture process for making the variant; pharmaceutical comprising the variant |
| 05/13/1997 | US5628930 Stabilization of fluorocarbon emulsions |
| 05/09/1997 | WO1997016535A2 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS |
| 05/09/1997 | WO1997016444A1 Antithrombotic n-amidinopiperidine and benzamidine derivatives |
| 05/09/1997 | WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | WO1997016405A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 05/09/1997 | WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/09/1997 | CA2236604A1 Antithrombotic n-amidinopiperidine and benzamidine derivatives |
| 05/07/1997 | EP0771818A2 Biotin derivatives |
| 05/07/1997 | EP0771324A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 05/07/1997 | EP0771204A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 05/07/1997 | EP0771146A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase |
| 05/07/1997 | EP0667780A4 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents. |
| 05/07/1997 | EP0621870B1 A human kunitz-type protease inhibitor variant |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |